These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15580248)

  • 1. West Nile virus: crossing the blood-brain barrier.
    Diamond MS; Klein RS
    Nat Med; 2004 Dec; 10(12):1294-5. PubMed ID: 15580248
    [No Abstract]   [Full Text] [Related]  

  • 2. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis.
    Wang T; Town T; Alexopoulou L; Anderson JF; Fikrig E; Flavell RA
    Nat Med; 2004 Dec; 10(12):1366-73. PubMed ID: 15558055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll gate for West Nile virus brain entry.
    Bradbury J
    Lancet Infect Dis; 2005 Jan; 5(1):9. PubMed ID: 15645544
    [No Abstract]   [Full Text] [Related]  

  • 4. DC-SIGN enhances infection of cells with glycosylated West Nile virus in vitro and virus replication in human dendritic cells induces production of IFN-alpha and TNF-alpha.
    Martina BE; Koraka P; van den Doel P; Rimmelzwaan GF; Haagmans BL; Osterhaus AD
    Virus Res; 2008 Jul; 135(1):64-71. PubMed ID: 18405996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How West Nile virus crosses the blood-brain barrier.
    Paterson R
    Lancet Neurol; 2005 Jan; 4(1):18. PubMed ID: 15645594
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristics of protein synthesis in the West Nile virus and the nature of infection in mosquito and mammalian cells].
    Liapustin VN; Chunikhin SP; Gritsun TS; Reshetnikov IA; Lashkevich VA
    Med Parazitol (Mosk); 1985; (3):50-4. PubMed ID: 2993835
    [No Abstract]   [Full Text] [Related]  

  • 7. In Vitro and In Vivo Blood-Brain Barrier Models to Study West Nile Virus Pathogenesis.
    Kumar M; Nerurkar VR
    Methods Mol Biol; 2016; 1435():103-13. PubMed ID: 27188553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of IFN-gamma in an experimental murine model of West Nile virus-induced seizures.
    Getts DR; Matsumoto I; Müller M; Getts MT; Radford J; Shrestha B; Campbell IL; King NJ
    J Neurochem; 2007 Nov; 103(3):1019-30. PubMed ID: 17854352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental infection of pigs with West Nile virus.
    Teehee ML; Bunning ML; Stevens S; Bowen RA
    Arch Virol; 2005 Jun; 150(6):1249-56. PubMed ID: 15770358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kinetics of proinflammatory cytokines in murine peritoneal macrophages infected with envelope protein-glycosylated or non-glycosylated West Nile virus.
    Shirato K; Miyoshi H; Kariwa H; Takashima I
    Virus Res; 2006 Oct; 121(1):11-6. PubMed ID: 16632038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Toll-like trigger for autoimmune disease.
    Bach JF
    Nat Med; 2005 Feb; 11(2):120-1. PubMed ID: 15692591
    [No Abstract]   [Full Text] [Related]  

  • 12. How NOD-ing off leads to Crohn disease.
    O'Neill LA
    Nat Immunol; 2004 Aug; 5(8):776-8. PubMed ID: 15282558
    [No Abstract]   [Full Text] [Related]  

  • 13. Toll-like receptors in rheumatoid arthritis joint destruction mediated by two distinct pathways.
    Ospelt C; Kyburz D; Pierer M; Seibl R; Kurowska M; Distler O; Neidhart M; Muller-Ladner U; Pap T; Gay RE; Gay S
    Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii90-ii91. PubMed ID: 15479881
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of immunosuppression on West Nile virus infection in hamsters.
    Mateo R; Xiao SY; Guzman H; Lei H; Da Rosa AP; Tesh RB
    Am J Trop Med Hyg; 2006 Aug; 75(2):356-62. PubMed ID: 16896148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [West Nile fever and West Nile encephalitis].
    Kurane I
    No To Shinkei; 2006 Jul; 58(7):547-52. PubMed ID: 16910463
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of tumor necrosis factor- alpha secretion and toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids from women with bacterial vaginosis.
    Zariffard MR; Novak RM; Lurain N; Sha BE; Graham P; Spear GT
    J Infect Dis; 2005 Jun; 191(11):1913-21. PubMed ID: 15871126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling.
    Shinohara H; Inoue A; Toyama-Sorimachi N; Nagai Y; Yasuda T; Suzuki H; Horai R; Iwakura Y; Yamamoto T; Karasuyama H; Miyake K; Yamanashi Y
    J Exp Med; 2005 Feb; 201(3):333-9. PubMed ID: 15699069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
    De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral peptides targeting the west nile virus envelope protein.
    Bai F; Town T; Pradhan D; Cox J; Ashish ; Ledizet M; Anderson JF; Flavell RA; Krueger JK; Koski RA; Fikrig E
    J Virol; 2007 Feb; 81(4):2047-55. PubMed ID: 17151121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Building an intestine--architectural contributions of commensal bacteria.
    Madara J
    N Engl J Med; 2004 Oct; 351(16):1685-6. PubMed ID: 15483290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.